| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/15/1995 | CA2178476A1 Pretargeting methods and compounds |
| 06/14/1995 | EP0656950A1 Tat-derived transport polypeptides |
| 06/14/1995 | EP0656884A1 Novel poly-iodated compounds, method of preparation and contrast product containing same |
| 06/14/1995 | EP0656762A1 Magnetic resonance arteriography with dynamic intravenous contrast agents |
| 06/14/1995 | EP0484328B1 Process for the preparation of 2,4,6-triiodo-5-amino-isophthalamide compounds |
| 06/14/1995 | EP0458841B1 Method for the use and synthesis of peptides |
| 06/13/1995 | US5424419 Contrast medium for magnetic resonace imaging, exothermic medium for hyperthermia; very stable |
| 06/13/1995 | US5424142 Gastrointestinal tract; improved images |
| 06/13/1995 | US5424057 Medical diagnosis |
| 06/13/1995 | US5424056 For diagnostic radiology of gastrointestinal tract |
| 06/13/1995 | EP0724449A4 Preservative for pharmaceutical products |
| 06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | WO1995015335A2 Pretargeting methods and compounds |
| 06/08/1995 | WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters |
| 06/08/1995 | WO1995015319A1 Paramagnetic chelates for nuclear magnetic resonance diagnosis |
| 06/08/1995 | WO1995015307A1 Biphenyl iodinated derivatives and their diagnostic use |
| 06/08/1995 | WO1995015306A1 Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purposes, and methods for preparing the complexes and pharmaceuticals |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | WO1995015153A1 Process for enhancing the stability of liposomal suspensions containing hydrophilic active agents |
| 06/08/1995 | WO1995015118A1 Gas microspheres for topical and subcutaneous application |
| 06/08/1995 | DE4341478A1 Antitumour compsn. comprising starch particles, cytostatic and contrast agent |
| 06/08/1995 | CA2617836A1 Nucleosides and oligonucleotides containing boron clusters |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177977A1 Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purposes, and methods for preparing the complexes and pharmaceuticals |
| 06/08/1995 | CA2177973A1 Process for enhancing the stability of liposomal suspensions containing hydrophilic active agents |
| 06/08/1995 | CA2177962A1 Biphenyl iodinated derivatives and their diagnostic use |
| 06/08/1995 | CA2177713A1 Gas microspheres for topical and subcutaneous application |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177136A1 Pretargeting methods and compounds |
| 06/07/1995 | EP0656368A1 Small-diameter composite composed of water-soluble carboxypolysaccharide and magnetic iron oxide |
| 06/07/1995 | EP0656121A1 Method for diagnosing and monitoring sepsis |
| 06/07/1995 | EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 06/07/1995 | EP0656037A1 Metal-mediated cross-coupling with ring-metalated porphyrins |
| 06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/06/1995 | US5422114 Compositions of iodoaniline derivatives and cellulose derivatives for visualization of the gastrointestinal tract |
| 06/06/1995 | US5422096 Hydroxy-aryl metal chelates for diagnostic NMR imaging |
| 06/06/1995 | US5422095 Low molecular weight polysaccharide complexes for radiation diagnosis |
| 06/06/1995 | US5422094 19 F labelled antibodies and fragments thereof as NMR imaging and spectroscopy agents |
| 06/06/1995 | CA1335819C Metal chelate containing diagnostic imaging contrast media |
| 06/01/1995 | WO1995014934A1 Nmr chiral shift reagent comprising sugar derivative |
| 06/01/1995 | WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME |
| 06/01/1995 | WO1995014726A1 Process for preparing polyazamacrocycles |
| 06/01/1995 | WO1995014678A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production |
| 06/01/1995 | WO1995014492A2 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| 06/01/1995 | WO1995014491A2 Metal-ion chelates with acidic saccharides and glycosaminoglycans |
| 06/01/1995 | CA2177470A1 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivityand kinetic-spatial profiles |
| 06/01/1995 | CA2177468A1 Metal-ion chelates with acidic saccharides and glycosaminoglycans |
| 06/01/1995 | CA2177271A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production |
| 06/01/1995 | CA2177074A1 P53-binding polypeptides and polynucleotides encoding same |
| 06/01/1995 | CA2176595A1 Process for preparing polyazamacrocycles |
| 05/31/1995 | EP0655252A1 Agent for suppressing the motor activity of gastrointestinal tracts |
| 05/31/1995 | EP0655247A1 Use of vincristine for the evaluation of substances at the neuroral level |
| 05/31/1995 | EP0655055A1 Tachykinin antagonists |
| 05/31/1995 | EP0654973A1 System of drug delivery to the lymphatic tissues |
| 05/31/1995 | EP0640067A4 Improved synthesis of ioversol. |
| 05/31/1995 | EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier |
| 05/30/1995 | US5420176 Contrast media for ultrasonic imaging |
| 05/30/1995 | US5419894 Complexing agents, complexes and complex salts |
| 05/30/1995 | US5419893 Aminopolycarboxylic acids and derivatives thereof for magnetic resonance imaging |
| 05/30/1995 | US5419892 Microfluidization of calcium/oxyanion-containing particles |
| 05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
| 05/30/1995 | CA1335714C Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 05/26/1995 | WO1995014039A1 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (lbp) and methods of their use |
| 05/26/1995 | WO1995013834A1 Chimeric oligonucleoside compounds |
| 05/26/1995 | WO1995013832A1 Immobilized labelling method |
| 05/26/1995 | CA2176259A1 Chimeric oligonucleoside compounds |
| 05/26/1995 | CA2175557A1 Immobilized labelling method |
| 05/23/1995 | US5417960 Gadolinium complexes, magnetic resonance imaging |
| 05/23/1995 | US5417959 Functionalized aza-crytand ligands for diagnostic imaging applications |
| 05/23/1995 | US5417958 Heavy metal clusters for use as imaging agents |
| 05/23/1995 | US5417213 Magnetic resonance arteriography with dynamic intravenous contrast agents |
| 05/23/1995 | CA1335677C Ultrasonic manometry process in a fluid by means of micro bubbles |
| 05/23/1995 | CA1335657C Three-dimensional cell and tissue culture system |
| 05/18/1995 | WO1995013096A1 Labelled diagnostic compositions and methods of their use |
| 05/18/1995 | WO1995013087A1 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| 05/18/1995 | CA2176005A1 Labelled diagnostic compositions and methods of their use |
| 05/17/1995 | EP0653063A1 In vitro test for dermal corrosive properties |
| 05/17/1995 | EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 05/17/1995 | EP0652885A1 Tetraazamacrocyclic metal complexes |
| 05/17/1995 | EP0652777A1 Small animal metastasis model |
| 05/17/1995 | EP0652746A1 Lymphatic delivery composition |
| 05/17/1995 | EP0371992B1 Ionophores as reagents for detecting ions |
| 05/16/1995 | US5416223 Iodinated esters |
| 05/16/1995 | US5416016 Method for enhancing transmembrane transport of exogenous molecules |
| 05/16/1995 | US5415867 High ratio active agent: lipid complex |
| 05/16/1995 | CA1335565C Liposomes: efficient loading and controlled release of amphiphatic molecules |
| 05/11/1995 | WO1995012818A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders |
| 05/11/1995 | WO1995012812A1 Method of monitoring patient compliance with medications prescriptions |
| 05/11/1995 | WO1995012414A1 Novel modified pf4 compositions and methods of use |
| 05/11/1995 | WO1995012386A1 Charged liposome preparation |
| 05/11/1995 | CA2174326A1 Charged liposome preparation |
| 05/11/1995 | CA2152954A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders |
| 05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 05/10/1995 | EP0496835B1 Solid tumor treatment method and composition |
| 05/10/1995 | CN1102348A Water insoluble manganese particles as magnetic resonance contrast enhancement agents |
| 05/09/1995 | US5414114 For magnetic resonance imaging |
| 05/09/1995 | US5413774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 05/04/1995 | WO1995011672A1 Detection of h. pylori in the stomach |
| 05/04/1995 | CA2174933A1 Detection of h. pylori in the stomach |